Cargando…
International reference pricing for prescription drugs: a landscape analysis
During the Trump administration, members of Congress and the administration proposed the introduction of international reference pricing (IRP) to Medicare in order to reduce US drug spending by benchmarking prices to those in other countries. Many other countries currently use IRP. We examined how U...
Autores principales: | Rand, Leah Z, Kesselheim, Aaron S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391192/ https://www.ncbi.nlm.nih.gov/pubmed/34464208 http://dx.doi.org/10.18553/jmcp.2021.27.9.1309 |
Ejemplares similares
-
International reference pricing of pharmaceuticals in the United States: Implications for potentially curative treatments
por: Sullivan, Sean D, et al.
Publicado: (2022) -
Cystic Fibrosis: Breakthrough Drugs at Break-the-Bank Prices
por: Orenstein, David M., et al.
Publicado: (2015) -
Anticipated efficiencies, real costs: Medicaid managed care organizations and the pharmacy benefit
por: Bendicksen, Liam, et al.
Publicado: (2022) -
Premarket Development Times for Innovative Vaccines––To What Extent Are the Coronavirus Disease 2019 (COVID-19) Vaccines Outliers?
por: Beall, Reed F, et al.
Publicado: (2021) -
Digital Social Media, Youth, and Nonmedical Use of Prescription Drugs: The Need for Reform
por: Mackey, Tim K, et al.
Publicado: (2013)